PANCREASE CAPSULES
PANCREASE CAPSULES
Discontinued
DIN Number
02242374
Drug Class
Human
Market Date
May 11, 2001
Company
HC
Janssen Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02242374
AIG Number0302964014
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
A09AA02 MULTIENZYMES (LIPASE, PROTEASE ETC)
Product Specifications
Dosage FormCapsule (Sustained-Release)
Route of AdministrationOral
AHFS Classification56:16.00
Health Canada Classification
ACTIVE INGREDIENTS (3)
AMYLASEActive
Strength: 20000 UNIT / SRC
Monograph: AMYLASE
LIPASEActive
Strength: 4500 UNIT / SRC
Monograph: LIPASE
PROTEASEActive
Strength: 25000 UNIT / SRC
Monograph: PROTEASE